October 25, 2007
Bevacizumab (Avastin) in the Treatment of Neovascular (Wet) Macular Degeneration
The Article for Bevacizumab (Avastin) in the Treatment of Neovascular (Wet) Macular Degeneration (NC – A38592, TN – A38516, ID – A38595) has been retired for all three CGS states, effective July 1, 2007.
